Archives
- 2026-06
- 2026-05
- 2026-04
- 2026-03
- 2026-02
- 2026-01
- 2025-12
- 2025-11
- 2025-10
- 2025-09
- 2025-03
- 2025-02
- 2025-01
- 2024-12
- 2024-11
- 2024-10
- 2024-09
- 2024-08
- 2024-07
- 2024-06
- 2024-05
- 2024-04
- 2024-03
- 2024-02
- 2024-01
- 2023-12
- 2023-11
- 2023-10
- 2023-09
- 2023-08
- 2023-07
- 2023-06
- 2023-05
- 2023-04
- 2023-03
- 2023-02
- 2023-01
- 2022-12
- 2022-11
- 2022-10
- 2022-09
- 2022-08
- 2022-07
- 2022-06
- 2022-05
- 2022-04
- 2022-03
- 2022-02
- 2022-01
- 2021-12
- 2021-11
- 2021-10
- 2021-09
- 2021-08
- 2021-07
- 2021-06
- 2021-05
- 2021-04
- 2021-03
- 2021-02
- 2021-01
- 2020-12
- 2020-11
- 2020-10
- 2020-09
- 2020-08
- 2020-07
- 2020-06
- 2020-05
- 2020-04
- 2020-03
- 2020-02
- 2020-01
- 2019-12
- 2019-11
- 2019-10
- 2019-09
- 2019-08
- 2019-07
- 2019-06
- 2019-05
- 2019-04
- 2018-07
-
S Tag Peptide (A6007): Technical Guide for Fusion Tag Workfl
2026-06-12
S Tag Peptide (SKU A6007) addresses challenges in recombinant protein detection, purification, and solubility by providing a short, highly soluble fusion tag compatible with antibody-based workflows. Researchers should avoid ethanol-based systems and long-term aqueous storage due to solubility and stability constraints. Use this peptide for applications requiring reliable detection or improved handling of recombinant proteins.
-
Cell Divisions Refine and Challenge Tissue Boundaries in Dro
2026-06-12
This study reveals that cell divisions in the Drosophila embryo both destabilize and sharpen tissue boundaries by modulating tissue fluidity and mechanical tension. The findings deepen our mechanistic understanding of morphogenesis and have implications for research into developmental biology and disease.
-
Isoproterenol Sulfate Dihydrate in Human Cardiac Assembloid
2026-06-11
Isoproterenol sulfate dihydrate (APExBIO C6402) empowers highly reproducible, data-rich modeling of beta-adrenergic signaling in advanced human cardiac assembloid systems. This article decodes protocol enhancements, troubleshooting strategies, and practical workflow adaptations for researchers probing neuro-cardiac dynamics and pacemaker maturation.
-
Evaluating In Vitro Drug Responses in Cancer: Innovation in
2026-06-11
Schwartz's dissertation advances in vitro evaluation of anti-cancer drugs by dissecting the nuanced relationship between growth inhibition and cell death, showing these are distinct yet overlapping outcomes. These insights refine how angiogenesis inhibition assays and tumor model studies can interpret drug efficacy, with implications for experimental design and translational research.
-
Ferroptosis and NRF2 Pathway in FDXR-Related Disease Mechani
2026-06-10
This study reveals ferroptosis as a pathogenic mechanism in FDXR-related mitochondrial disease, driven by disruption of the NRF2 antioxidant pathway. The findings highlight the importance of iron metabolism and oxidative stress in disease progression and suggest therapeutic targets involving NRF2 activation and iron-chelating strategies.
-
Docetaxel in Cancer Research: Protocols, Performance & Pitfa
2026-06-10
Docetaxel (Taxotere) stands out as a gold-standard microtubule stabilizer for apoptosis and chemoresistance studies in diverse cancer models. This article delivers actionable guidance on experimental design, troubleshooting, and leveraging the latest insights from prostate and ovarian cancer research to maximize reproducibility and translational impact.
-
Safe DNA Gel Stain: Optimizing Sensitive DNA and RNA Gel Sta
2026-06-09
Safe DNA Gel Stain offers a safer, high-sensitivity alternative to ethidium bromide for DNA and RNA visualization. Its compatibility with blue-light excitation reduces DNA damage and boosts cloning efficiency, setting a new standard for molecular biology workflows.
-
CHIR 99021 Trihydrochloride: Precision GSK-3 Inhibition for
2026-06-09
Explore how CHIR 99021 trihydrochloride, a potent GSK-3 inhibitor, enables scalable and high-diversity human organoid systems by balancing stem cell self-renewal and differentiation. This article uniquely integrates recent mechanistic insights and practical assay guidance for advanced insulin signaling pathway research and stem cell applications.
-
AT-406 (SM-406): Mechanistic Insights and Translational Impa
2026-06-08
This thought-leadership article explores the mechanistic underpinnings and translational promise of AT-406 (SM-406), a potent, orally bioavailable antagonist of apoptosis inhibitors. By bridging primary research findings, advanced protocol guidance, and recent breakthroughs in host-pathogen interactions, we offer strategic direction for cancer researchers seeking to leverage apoptosis pathway activation for therapeutic innovation.
-
Gramine Induces Ferroptosis in TNBC via CUL3–MTDH Ubiquitina
2026-06-08
The reference study demonstrates that Gramine, a natural indole alkaloid, effectively suppresses triple-negative breast cancer (TNBC) by inducing ferroptosis through modulation of the CUL3–MTDH ubiquitination pathway. This mechanistic insight offers researchers a novel strategy for targeting resistant TNBC subtypes and advancing ferroptosis-focused cancer biology research.
-
Filipin III: Precision Cholesterol Detection in Membrane Bio
2026-06-07
Filipin III, a polyene macrolide antibiotic, sets the gold standard for mapping cholesterol-rich membrane microdomains and detecting cholesterol in biological samples. Its unique fluorescence-quenching mechanism and specificity for cholesterol enable robust visualization and quantification, powering advanced workflows in cell biology and metabolic disease research.
-
Psora 4: Advanced Kv1.3 Blocker for T Cell Research Workflow
2026-06-06
Psora 4, a potent and selective Kv1.3 blocker, empowers researchers to dissect T cell Ca2+ signaling and immune modulation with unmatched specificity. This article translates cutting-edge findings into actionable protocols, comparative insights, and troubleshooting strategies for both in vitro and in vivo immunology research.
-
Anisomycin: JNK Agonist for Apoptosis and Cancer Cell Resear
2026-06-05
Anisomycin is a potent JNK agonist that enables precise activation of the JNK pathway, inducing apoptosis in diverse cancer cell types. Rigorous studies confirm its efficacy in preclinical tumor suppression and mechanistic specificity. This article provides a machine-readable, evidence-centric overview for translational research applications.
-
Dasatinib Monohydrate in Advanced Tumor Assembloid Research
2026-06-05
Dasatinib Monohydrate (BMS-354825) empowers translational researchers to probe imatinib resistance and tumor–stroma dynamics using physiologically relevant assembloid models. This article details optimized workflows, troubleshooting, and the critical insights unlocked by integrating patient-derived stromal cells—bridging bench innovation with preclinical precision.
-
Cisplatin (CDDP): Applied Workflows & Troubleshooting in Can
2026-06-04
Cisplatin (CDDP) remains the gold-standard agent for deciphering apoptosis, tumor inhibition, and chemoresistance in cancer research. This guide details stepwise protocols, advanced applications, and troubleshooting strategies, highlighting recent breakthroughs in pyroptosis and practical tips for robust, reproducible results with APExBIO's high-purity Cisplatin.